A uniform standardized assessment of opioid treatment does not exist to guide management decisions for patients in skilled nursing facilities (SNFs). The purpose of this study is to determine if (1) a novel opioid assessment tool can be feasibly used to support clinician decision-making in opioid managemen...
Identifying the factors that contribute to the incidence of disability in older adults and the activities that can be engaged in to reduce the risk of disability is critical to the health of older adults. This study aimed to assess the impact of social activities on the incidence of disability during follo...
Patients from ethnically minoritized communities often face disparities in health care due to language and cultural barriers. This study aimed to compare health care use and end-of-life outcomes between Chinese-speaking residents living in language-concordant and language-discordant long-term care (LTC) ho...
To examine the associations between COVID-19 pandemic waves (1–4) and prevalent antipsychotic, antidepressant, benzodiazepine, anticonvulsant, and opioid use among assisted living (AL) residents, by setting (dementia care vs other).
Pain management in post-acute care (PAC) requires careful balance, with both opioid use and inadequate pain treatment linked to poor outcomes. We describe opioid use among older adults following discharge from PAC for hip fracture in skilled nursing facilities (SNFs) and inpatient rehabilitation facilities...
Medication optimization is a hot topic in post-acute and long-term care and a focus of AMDA’s very popular Drive to Deprescribe (D2D) initiative. Now practitioners have yet another opportunity to address their deprescribing challenges with a new quarterly D2D podcast. The first program addresses Optimizing...
Proper initiation and reduction of opioids is important in providing effective and safe pain relief to Veterans with dementia, including in Community Living Centers (CLCs). We examined the trends in aggregated monthly risk-adjusted opioid administration days and dosage over 3 opioid safety regulatory perio...